179 related articles for article (PubMed ID: 29702999)
1. Immunological markers as predictors of developing steroid-induced diabetes mellitus in pemphigus vulgaris patients: An observational study.
Dănescu AS; Bâldea I; Leucuţa DC; Lupan I; Samaşca G; Sitaru C; Chiorean R; Baican A
Medicine (Baltimore); 2018 Apr; 97(17):e0463. PubMed ID: 29702999
[TBL] [Abstract][Full Text] [Related]
2. Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris.
Daneshpazhooh M; Kamyab K; Kalantari MS; Balighi K; Naraghi ZS; Shamohammadi S; Mortazavizadeh SM; Ramezani A; Chams-Davatchi C
Clin Exp Dermatol; 2014 Jan; 39(1):41-7. PubMed ID: 23782219
[TBL] [Abstract][Full Text] [Related]
3. Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.
Mortazavi H; Shahdi M; Amirzargar AA; Naraghi ZS; Valikhani M; Daneshpazhooh M; Vasheghani-Farahani A; Sedaghat M; Chams-Davatchi C
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):53-6. PubMed ID: 19279360
[TBL] [Abstract][Full Text] [Related]
4. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
[TBL] [Abstract][Full Text] [Related]
5. Correlation of conventional and conformational anti-desmoglein antibodies with phenotypes and disease activities in patients with pemphigus vulgaris.
Li Z; Zhang J; Xu H; Jin P; Feng S; Wang B
Acta Derm Venereol; 2015 Apr; 95(4):462-5. PubMed ID: 25178305
[TBL] [Abstract][Full Text] [Related]
6. Analysis of immunological profile, clinical features and response to treatment in pemphigus.
Bardazzi F; Balestri R; Ismaili A; LA Placa M; Barisani A; Patrizi A
G Ital Dermatol Venereol; 2017 Dec; 152(6):569-577. PubMed ID: 27352177
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in Pemphigus Patients Measured by Area Index and Intensity Score.
Patsatsi A; Kyriakou A; Giannakou A; Pavlitou-Tsiontsi A; Lambropoulos A; Sotiriadis D
Acta Derm Venereol; 2014 Mar; 94(2):203-6. PubMed ID: 23995461
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of anti-desmoglein-1 and anti-desmoglein-3 autoantibody titers in pemphigus patients at the time of the initial diagnosis and after clinical remission.
Russo I; De Siena FP; Saponeri A; Alaibac M
Medicine (Baltimore); 2017 Nov; 96(46):e8801. PubMed ID: 29145342
[TBL] [Abstract][Full Text] [Related]
9. Orodigital pemphigus vulgaris: a pathogenic role of anti-desmoglein-3 autoantibodies in pemphigus paronychia?
Laffitte E; Panizzon RG; Borradori L
Dermatology; 2008; 217(4):337-9. PubMed ID: 18799879
[TBL] [Abstract][Full Text] [Related]
10. Detailed profiling of anti-desmoglein autoantibodies identifies anti-Dsg1 reactivity as a key driver of disease activity and clinical expression in pemphigus vulgaris.
Naseer SY; Seiffert-Sinha K; Sinha AA
Autoimmunity; 2015 Jun; 48(4):231-41. PubMed ID: 25384535
[TBL] [Abstract][Full Text] [Related]
11. Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission.
Daneshpazhooh M; Zafarmand Sedigh V; Balighi K; Hosseini SH; Ramezani A; Kalantari MS; Ghandi N; Ghiasi M; Nikoo A; Chams-Davatchi C
J Am Acad Dermatol; 2016 Jun; 74(6):1160-5. PubMed ID: 26896293
[TBL] [Abstract][Full Text] [Related]
12. Pemphigus foliaceus evolving into pemphigus vulgaris: a probable example of 'intermolecular epitope spreading' confirmed by enzyme-linked immunosorbent assay study.
Pigozzi B; Peserico A; Schiesari L; Alaibac M
J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):242-4. PubMed ID: 18211424
[No Abstract] [Full Text] [Related]
13. Pemphigus Herpetiformis With Autoantibodies to Desmoglein 1 and 3.
Galvañ-Pérez Del Pulgar JI; Tercedor-Sánchez J; Jiménez-Gallo D; Linares-Barrios M
Actas Dermosifiliogr; 2016 Nov; 107(9):785-786. PubMed ID: 27340117
[No Abstract] [Full Text] [Related]
14. Anti-desmoglein-1 levels as predictor of prednisolone tapering in pemphigus vulgaris patients treated with rituximab.
Balighi K; Sakhi RS; Daneshpazhooh M; Mahmoudi H; Teimourpour A; Tavakolpour S
Dermatol Ther; 2018 Nov; 31(6):e12671. PubMed ID: 30246907
[No Abstract] [Full Text] [Related]
15. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
16. The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies.
Szabados H; Bősze S; Silló P; Kárpáti S; Hudecz F; Uray K
J Pept Sci; 2013 Feb; 19(2):84-94. PubMed ID: 23297065
[TBL] [Abstract][Full Text] [Related]
17. Correlation of immunological profile with phenotype and disease outcome in pemphigus.
Herrero-González JE; Iranzo P; Benítez D; Lozano F; Herrero C; Mascaró JM
Acta Derm Venereol; 2010 Jul; 90(4):401-5. PubMed ID: 20574606
[TBL] [Abstract][Full Text] [Related]
18. Two cases of pemphigus vulgaris in remission showing high titer of anti-desmoglein 3 antibodies.
Inaoki M; Oishi K; Nishijima C; Takehara K; Ishii K
J Dermatol; 2019 Mar; 46(3):e92-e94. PubMed ID: 30144149
[No Abstract] [Full Text] [Related]
19. Salivary Samples for the Diagnosis of Pemphigus vulgaris Using the BIOCHIP Approach: a Pilot Study.
Russo I; Saponeri A; Michelotto A; Alaibac M
In Vivo; 2017 Jan; 31(1):97-99. PubMed ID: 28064226
[TBL] [Abstract][Full Text] [Related]
20. Pemphigus vegetans Neumann type with anti-desmoglein and anti-periplakin autoantibodies.
Cozzani E; Christana K; Mastrogiacomo A; Rampini P; Drosera M; Casu M; Murialdo G; Parodi A
Eur J Dermatol; 2007; 17(6):530-3. PubMed ID: 17951135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
